US drug approvals
47 approvals with a product on the US market
- Gabapentin ANDA203611 · approved 23 Jun 2026
- Lisdexamfetamine Dimesylate ANDA202802 · approved 25 Aug 2023
- Methylphenidate ANDA210924 · approved 19 Jun 2020
- Deferasirox ANDA208697 · approved 13 Dec 2019
- Albendazole ANDA208094 · approved 20 May 2019
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.